Skip to site menu Skip to page content

Subcutaneous Drug Delivery: Adapting to High-Viscosity, Target-Volume Demands

By Ypsomed
In this article, Thomas Fontanellaz, Category Lead YpsoMate 2.25, Reto Jost, Category Lead Large Volume Injectors, and Andreas Schneider, PhD, Head of Innovation, all at Ypsomed, discuss how the company is addressing the growing need for subcutaneous injections that accommodate higher volumes and viscosities, with innovative self-injection devices designed to enhance patient comfort and adherence.
Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Related Content